`

Cardiff Oncology

Biotechnology Research

Specialities :
Oncology
Response monitoring
Cancer monitoring
And mutation detection
revenue-icon Revenue
< 1M
funding-icon Total Funding
$15.0M
size-icon Size
51 - 200

Frequently Asked Questions About Cardiff Oncology

What does Cardiff oncology do?+

Cardiff Oncology is a clinical-stage biotechnology company, headquartered in San Diego, CA, leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers. Our lead asset is onvansertib, a PLK1 inhibitor being evaluated in combination with standard-of-care (SoC) therapeutics in clinical programs targeting indications such as KRAS/NRAS-mutated metastatic colorectal cancer (mCRC) and metastatic pancreatic ductal adenocarcinoma (mPDAC), as well as in investigator-initiated trials in triple negative breast cancer (TNBC) and small cell lung cancer (SCLC). These programs and Cardiffs broader development strategy are designed to target tumor vulnerabilities in order to overcome treatment resistance...

What are Cardiff oncology's specialties? +

Oncology,response monitoring,cancer monitoring,and mutation detection

What is Cardiff oncology's industry? +

Cardiff oncology operates in the Biotechnology research industry.

What is Cardiff oncology's revenue? +

Cardiff oncology's revenue is < 1m

What is Cardiff oncology's company size? +

Cardiff oncology has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.